Topas raises €22m in Series B financinin...Topas Therapeutics GmbH will use the €22m proceeds from a Series B Financing to advance two pipeline candidates. more ➔
Siemens launches COVID-19 antigen lateral...Siemens Healthineers has launched its Clinitest Rapid COVID-19 Antigen Test in Europe, which can identify persons infected with SARS-CoV-2 in 15 minutes. more ➔
Priothera closes €30m Series A financingPriothera Ltd. wants to use €30m from a Series A financing to develop a licenced therapy for acute myeloid leukemia (AML). more ➔
COVID-19 jab: EU signs contract with JNJJohnson & Johnson (JNJ) has inked a contract with the European Commission to supply 200 million doses of its COVID-19 vaccine to the European Union. more ➔
Santhera ends development of idebenoneSwiss Santhera Pharmaceuticals has discontinued Phase III development of its DMD drug and will restructure its pipeline. more ➔
Nobel Prize in Physiology for HCV pioneersThe Nobel Prize in Physiology or Medicine goes to Harvey J. Alter, Michael Houghton and Charles M. Ric more ➔
Swiss Sophia Genetics to expand globallySwiss Sophia Genetics has raised $110m, to expand marketing of its AI-driven cancer and genetic disease decision support platform globally. more ➔
EIB and EC launch circular bioeconomy fundThe European Commission (EC) and the European Investment Bank (EIB) have launched a circular bioeconomy fund with a target size of €250m. more ➔ · more ➔
Dewpoint Therapeutics raise $77m in Series...A $77 Series B financing allows Dewpoint Therapeutics Inc to select a lead programme from its new drug class of molecular condensates and push proof-of-concept studies. more ➔
Kurma Partners close diagnostics fund at ...The only investment fund dedicated to breakthrough diagnostics, Kurma Diagnostics 2, had its first closing at €50m. more ➔